Yujun F. Shi

Key Laboratory Of Transplant Engineering And Immunology
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 103 publications

Whole-Exome Sequencing Identifies Frequent AHNAK2 Mutations With Prognostic Significance in Undifferentiated Primary Liver Carcinoma.

Whole-Exome Sequencing Identifies Frequent AHNAK2 Mutations With Prognostic Significance in Undifferentiated Primary Liver Carcinoma.

Journal: The American journal of surgical pathology

Published: April 24, 2026

LPCAT1 and MRPL9 Promote Hepatocellular Carcinoma Progression via AKT Phosphorylation and Define a Mitochondrial Prognostic Model.

LPCAT1 and MRPL9 Promote Hepatocellular Carcinoma Progression via AKT Phosphorylation and Define a Mitochondrial Prognostic Model.

Journal: Cancers

Published: February 06, 2026

A selective BRG1 inhibitor targeting bromodomain sensitizes hepatocellular carcinoma to chemoradiotherapy by disrupting the DNA damage response.

A selective BRG1 inhibitor targeting bromodomain sensitizes hepatocellular carcinoma to chemoradiotherapy by disrupting the DNA damage response.

Journal: Chinese medical journal

Published: January 12, 2026

In vivo generation of fibrolytic macrophages via LNP-CSF1 mRNA attenuates liver fibrosis.

In vivo generation of fibrolytic macrophages via LNP-CSF1 mRNA attenuates liver fibrosis.

Journal: Journal of nanobiotechnology

Published: December 12, 2025

Optimization of the magnetic difference calibration method on Huan Liu-3 tokamak.

Optimization of the magnetic difference calibration method on Huan Liu-3 tokamak.

Journal: The Review of scientific instruments

Published: October 18, 2025

Publisher Correction: Acetylation profiling by Iseq-Kac reveals insights into HSC aging and lineage decision.

Publisher Correction: Acetylation profiling by Iseq-Kac reveals insights into HSC aging and lineage decision.

Journal: Nature chemical biology

Published: June 04, 2025

KAT2A-driven succinylation of SRSF11 enforces spliceosome-mediated RAD52 splicing to promote homologous recombination and radioresistance in hepatocellular carcinoma.

KAT2A-driven succinylation of SRSF11 enforces spliceosome-mediated RAD52 splicing to promote homologous recombination and radioresistance in hepatocellular carcinoma.

Journal: Signal transduction and targeted therapy

Published: June 03, 2025

Avian GCGR-mediated continuous fat utilization offers perspectives for obesity treatment.

Avian GCGR-mediated continuous fat utilization offers perspectives for obesity treatment.

Journal: Nature communications

Published: January 29, 2025

Loss of NUMB promotes hepatomegaly and hepatocellular carcinoma through the AKT/glycogen/hippo signaling.

Loss of NUMB promotes hepatomegaly and hepatocellular carcinoma through the AKT/glycogen/hippo signaling.

Journal: Oncogene

Published: January 03, 2025

Arginase 1 promotes hepatic lipogenesis by regulating ERK2/PPARγ signaling in a non-canonical manner.

Arginase 1 promotes hepatic lipogenesis by regulating ERK2/PPARγ signaling in a non-canonical manner.

Journal: Nature communications

Published: December 19, 2024

Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study.

Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study.

Journal: Radiology

Published: November 05, 2024

Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.

Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study.

Journal: Signal transduction and targeted therapy

Published: November 03, 2024

Showing 1-12 of 103

Last Updated: 09/26/2026